US Patent Issued to BPGbio, Henry M. Jackson Foundation for the Advancement of Military Medicine on June 3 for "Markers for the diagnosis of biochemical recurrence in prostate cancer" (Massachusetts, Maryland Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,320,812, issued on June 3, was assigned to BPGbio Inc. (Framingham, Mass.) and Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. (Bethesda, Md.).

"Markers for the diagnosis of biochemical recurrence in prostate cancer" was invented by Michael Andrew Kiebish (Millis, Mass.), Niven Rajin Narain (Cambridge, Mass.), Rangaprasad Sarangarajan (Boylston, Mass.), Viatcheslav R. Akmaev (Sudbury, Mass.), Leonardo Rodrigues (Ashland, Mass.), Lixia Zhang (Natick, Mass.), Eric Milliman (Natick, Mass.), Shiv Srivastava (Potomac, Md.), Albert Dobi (Rockville, Md.) and Jennifer Cullen (Gaithersburg, Md.).

According to the abstract* released by the U.S. Patent & Trademark Offic...